ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	155.15	188.66	114.85	147.44	326.03	189.68
Short-Term Investments	410.18	250.21	301.98	373.27	305.93	507.75
Cash & Short-Term Investments	565.33	438.87	416.82	520.71	631.96	697.43
Cash Growth	63.43%	5.29%	-19.95%	-17.60%	-9.39%	47.29%
Accounts Receivable	98.21	98.27	62.2	64.37	48.25	35.78
Other Receivables	12.15	4.08	0.89	0.98	2.04	2.09
Receivables	110.36	102.35	63.08	65.34	50.28	37.87
Inventory	61.04	35.82	6.64	7.88	9.68	6.34
Prepaid Expenses	51.55	39.09	21.4	23.89	25.69	18.61
Total Current Assets	788.28	616.13	507.94	617.82	717.62	760.25
Property, Plant & Equipment	48.24	56.47	61.59	66.32	56.44	12.7
Long-Term Investments	-	-	-	3.6	1.3	2.3
Other Intangible Assets	105.52	65.49	-	-	1.11	2.59
Other Long-Term Assets	34.83	10.87	18.28	12.38	6.15	5.34
Total Assets	976.87	748.96	587.81	700.12	782.62	783.18
Accounts Payable	19.08	17.54	12.75	6.88	8.49	7.22
Accrued Expenses	236.33	197.72	103.58	80.89	92.39	64.17
Current Portion of Leases	8.95	9.41	9.31	8.3	5.09	3.43
Other Current Liabilities	79.58	29.58	-	-	-	-
Total Current Liabilities	343.95	254.25	125.63	96.07	105.97	74.83
Long-Term Leases	40.42	47.8	52.7	56.13	44.46	6.36
Other Long-Term Liabilities	15.32	15.15	9.07	7.03	5.18	2.86
Total Liabilities	399.69	317.2	187.4	159.23	155.61	84.05
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	2,924	2,863	2,771	2,695	2,613	2,403
Retained Earnings	-2,348	-2,431	-2,370	-2,154	-1,986	-1,704
Comprehensive Income & Other	0.86	0.02	-0.98	-0.19	0.04	0.3
Shareholders' Equity	577.18	431.76	400.41	540.89	627.01	699.14
Total Liabilities & Equity	976.87	748.96	587.81	700.12	782.62	783.18
Total Debt	49.37	57.21	62	64.43	49.55	9.8
Net Cash (Debt)	515.96	381.66	354.82	456.28	582.41	687.63
Net Cash Growth	78.67%	7.56%	-22.24%	-21.66%	-15.30%	45.22%
Net Cash Per Share	3.11	2.33	2.19	2.84	3.70	4.67
Filing Date Shares Outstanding	166.39	164.77	162.23	161.2	160.05	155.34
Total Common Shares Outstanding	166.35	164.65	162.06	161.01	159.64	155.28
Working Capital	444.34	361.87	382.31	521.76	611.65	685.42
Book Value Per Share	3.47	2.62	2.47	3.36	3.93	4.50
Tangible Book Value	471.67	366.27	400.41	540.89	625.9	696.55
Tangible Book Value Per Share	2.84	2.22	2.47	3.36	3.92	4.49
Machinery	-	10.42	10.42	10.54	9.08	5.95
Leasehold Improvements	-	3.75	3.7	3.7	4.03	2.56

Source: S&P Capital IQ. Standard template. Financial Sources.